Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Pharvaris | 2026 | Post-IPO Equity | Undisclosed | Zug |
| Farther | 2026 | Series D | $72.0M | San Francisco |
| Fresha | 2026 | Series C | Undisclosed | London |
| VAST Data | 2026 | Series F | $500.0M | New York |
| Doctolib | 2026 | Secondary Market | Undisclosed | Paris |
| Seaport Therapeutics | 2026 | Grant | $15.0M | Boston |
| Bold | 2025 | Venture - Series Unknown | $40.0M | Bogotá |
| QI Tech | 2025 | Series B | $63.0M | São Paulo |
| Neon | 2025 | Series E | $25.0M | São Paulo |
| Javara Research | 2025 | Series C | $6.6M | Winston Salem |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Pharvaris | Post-IPO Equity | Undisclosed | Zug, Switzerland |
| 2 | Farther | Series D | $72.0M | San Francisco, United States |
| 3 | Fresha | Series C | Undisclosed | London, United Kingdom |
| 4 | VAST Data | Series F | $500.0M | New York, United States |
| 5 | Doctolib | Secondary Market | Undisclosed | Paris, France |
| 6 | Seaport Therapeutics | Grant | $15.0M | Boston, United States |
| 7 | Bold | Venture - Series Unknown | $40.0M | Bogotá, Colombia |
| 8 | QI Tech | Series B | $63.0M | São Paulo, Brazil |
| 9 | Neon | Series E | $25.0M | São Paulo, Brazil |
| 10 | Javara Research | Series C | $6.6M | Winston Salem, United States |
Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.
Farther is an intelligent wealth platform that enhances wealth management for clients throughout their financial lives.
Fresha is a marketplace platform that allows users to find beauty, wellness, and self-care services nearby.
VAST Data offers an AI Operating System that integrates storage, database, and compute engine capabilities into a single software platform.
Doctolib is an online and mobile booking platform that helps users find doctors and make appointments.
Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.
Bold creates financial tools that allow users to increase sales by receiving card payments.
QI Tech is a fintech platform that provides APIs enabling businesses to offer financial products to their customers.
Neon is a digital bank that offers credit cards, personal loans, and investment products, among other services.
Javara is an integrated research organization focused on healthcare and the research industry.
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics.
Vida Health is a virtual care platform that provides health coaching from experienced health care providers and medical institutions.
Author Health provides care and treatment for Medicare Advantage recipients with substance use disorders and serious mental illness.
Talos is an end-to-end crypto trading platform that provides digital asset trading technology for lenders, brokers, and investors.
SciNeuro is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases.
Allonnia is an environmental biotechnology company focused on metals and mining, plastics and PFAS, plus other emerging contaminants.
Anthropic is an AI safety and research company that builds reliable, interpretable, and steerable AI systems.
Runway offers generative AI tools for creating images, videos, and simulations, enabling new creative workflows through AI.
Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
OneStream Software is an independent software company that develops a financial planning and analysis software.
Port is an agentic engineering platform enabling the software industry to transition from manual workflows to autonomous engineering.
ByteDance is a technology company that develops content creation platforms and services.
SmartHR provides a cloud-native human resources management platform for businesses.
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process.
Snapmint is a financial technology company that provides cardless, paperless, online shopping EMIs to consumers
General Atlantic has invested in 120 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
General Atlantic's top investment sectors include Health Care, Biotechnology, Financial Services, FinTech, Artificial Intelligence (AI). The firm invests across 58 different industry categories.
Among tracked funding rounds, Anthropic received $30.0B in a Series G round. General Atlantic's total known invested capital is $43.5B.
General Atlantic's average investment size is $489.1M across its portfolio of 120 companies.
Recent General Atlantic portfolio additions include Pharvaris, Farther, Fresha, VAST Data, Doctolib. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors